Novartis (NVS) Tops Q3 EPS by 12c

Novartis (NYSE: NVS) reported Q3 EPS of $2.06, $0.12 better than the analyst estimate of $1.94. Revenue for the quarter came in at $12.82 billion versus the consensus estimate of $12.79 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• U.S. presses Meta to agree to A.I. reviews as security concerns rise - NYT